Interleukin 35 ameliorates myocardial ischemia‐reperfusion injury by activating the gp130‐STAT3 axis-Reference-Cited by-同舟云学术

Interleukin 35 ameliorates myocardial ischemia‐reperfusion injury by activating the gp130‐STAT3 axis

Published:2020-01-09 Issue:2 Volume:34 Page:3224-3238
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Zhou Xingdi¹²,Xia Ni¹²,Lv Bingjie¹²,Tang Tingting¹²,Nie Shaofang¹²,Zhang Min¹²,Jiao Jiao¹²,Liu Jianfeng³,Xu Chanjuan³,Hou Guofei³,Yang Xiangping⁴,Hu Yu²⁵,Liao Yuhua¹²,Cheng Xiang¹²

Affiliation:

1. Department of Cardiology Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China

2. Key Laboratory of Biological Targeted Therapy of Education Ministry and Hubei Province Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China

3. Sino‐France Laboratory of cellular signaling, Key Laboratory of Molecular Biophysics of Ministry of Education College of Life Science and Technology and Collaborative Innovation Center for Genetics and Development Huazhong University of Science and Technology Wuhan Hubei China

4. School of Basic Medicine Tongji Medical College Huazhong University of Science and Technology Wuhan China

5. Institute of Hematology Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.201901718RR

Reference52 articles.

1. Reducing myocardial infarct size: challenges and future opportunities